Sg. Brickley et al., CNQX increases GABA-mediated synaptic transmission in the cerebellum by anAMPA/kainate receptor-independent mechanism, NEUROPHARM, 41(6), 2001, pp. 730-736
GABA(A) receptor-mediated inhibitory synaptic transmission within the CNS i
s often studied in the presence of glutamate receptor antagonists. However,
for nearly a decade it has been known that. in the hippocampus, one of the
most commonly used alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic ac
id (AMPA)/kainate receptor antagonists, 6-cyano-7-nitroquinoxaline-2,3-dion
e (CNQX), can increase the frequency of spontaneous GABA(A) receptor-mediat
ed postsynaptic currents (sIPSCs). In the present study we examined the eff
ect of CNQX and related compounds on GABA-mediated synaptic transmission in
the cerebellum. At various stages of development, low concentrations of CN
QX increased the frequency of sIPSCs recorded from granule cells. This effe
ct was independent of the blocking action of CNQX on ionotropic glutamate r
eceptors, as it was not observed with the broad-spectrum glutamate receptor
antagonist kynurenate. No increase in sIPSC frequency was observed with th
e NMDA receptor antagonists D-AP5 or 7-CIK, the selective AMPA receptor ant
agonists GYKI 52466 or GYKI 53655, or the kainate receptor antagonist NS-10
2. In contrast, two other quinoxaline derivatives. NBQX and DNQX, were capa
ble of increasing sIPSC frequency. These results demonstrate that the novel
excitatory action of CNQX, unrelated to blockade of ionotropic glutamate r
eceptors, is not restricted to the hippocampus and can be observed with str
ucturally related compounds. (C) 2001 Published by Elsevier Science Ltd.